No Detail Found!

Atractylenolide I regulates colorectal cancer cells' biological processes and glycolysis via KRT7

Author(s)
Yutao Xie Beijing Anzhen Nanchong Hospital, Capital Medical University & Nanchong Central Hospital Nanchong Key Laboratory of Individualized Drug Therapy
Yunlong Wang Beijing Anzhen Nanchong Hospital, Capital Medical University & Nanchong Central Hospital Nanchong Key Laboratory of Individualized Drug Therapy
Lin Chen Beijing Anzhen Nanchong Hospital, Capital Medical University & Nanchong Central Hospital Nanchong Key Laboratory of Individualized Drug Therapy
Junshan Long Beijing Anzhen Nanchong Hospital, Capital Medical University & Nanchong Central Hospital Nanchong Key Laboratory of Individualized Drug Therapy
Ruyong Zhu Chongqing Hospital of Traditional Chinese Medicine Preparation Center,,
Huihui Zheng Pharmacy Department of Chong Qing Bishan District TCM Hospital,,
Abstract
Atractylenolide I (ATL-I) can interfere with Colorectal cancer (CRC) cell proliferation by changing apoptosis, glucose metabolism, and other behaviors, making it an effective drug for inhibiting CRC tumor growth. In this paper, we investigated the interactions between ATL-I and Keratin 7 (KRT7), a CRC-specific marker, to determine the potential pathways by which ATL-I inhibits CRC development. The KRT7 expression level in CRC was predicted online using the GEPIA website and then validated. HCT-116 cells' proliferation and invasion ability were determined using MTT and Transwell assays and the apoptosis rate using flow cytometry. Glucose consumption, lactate and ATP production levels were measured in HCT-116 cells using appropriate kits. Created the subcutaneous graft tumor model and identified the ATL-I effect in vivo. KRT7 was highly increased in CRC cells, KRT7 knockdown and overexpression prevented and encouraged malignant biological processes, as well as glycolysis. ATL-I acts by inhibiting the expression of KRT7, which can greatly inhibit the formation of CRC transplantation tumors in nude mice. ATL-I can impede the malignant biological process and glycolysis of CRC cells by inhibiting KRT7 expression in vitro and in vivo.
Publication Details
Page(s) 1213-1222
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 6, Year: 2024

Request the full text from PASTIC

Keywords
colorectal cancer, Glycolysis, Keratin 7, Atractylenolide I
References
Aldea M,Andre F,Marabelle A,Dogan S,Barlesi F,Soria JC .2021 .Overcoming resistance to tumortargeted and immune-targeted therapies. Cancer Discov, 11(4) : 874-899.
An Q,Liu T,Wang MY,Yang YJ,Zhang ZD,Liu ZJ,Yang B .2021 .KRT7 promotes epithelialmesenchymal transition in ovarian cancer via the TGF-beta/Smad2/3 signaling pathway. Oncol. Rep, 45(2) : 481-492.
Andreucci E,Peppicelli S,Ruzzolini J,Bianchini F,Biagioni A,Papucci L,Magnelli L,Mazzanti B,Stecca B,Calorini L B .2020 .The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells. J. Mol. Med, 98(10) : 1431-1446.
Bayrak R,Haltas H,Yenidunya S H .2012 .The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: Cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody. , 7 : 9.
Bhattacharya B,Mohd Omar MF,Soong R .2016 .The Warburg effect and drug resistance. Br. J. Pharmacol., 173(6) : 970-979.
Calibasi-Kocal G,Pakdemirli A,Bayrak S,Ozupek NM,Sever T,Basbinar Y,Ellidokuz H,Yigitbasi T H .2019 .Curcumin effects on cell proliferation, angiogenesis and metastasis in colorectal cancer. J. Buon., 24(4) : 1482-1487.
Chan KWK,Chung HY,Ho WS .2020 .Anti-tumor activity of Atractylenolide I in human colon adenocarcinoma in vitro. Molecules, 25(1) : 212.
Chang CH,Qiu J,O'Sullivan D,Buck MD,Noguchi T,Curtis JD,Chen Q,Gindin M,Gubin MM,van der Windt GJ,Tonc E,Schreiber RD,Pearce EJ,Pearce EL .2015 .Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell, 162(6) : 1229-1241.
Chen JF,Wu SW,Shi ZM,Hu B .2023 .Traditional Chinese medicine for colorectal cancer treatment: Potential targets and mechanisms of action. Chin. Med, 18(1) : 14.
Chen S,Su T,Zhang Y,Lee A,He J,Ge Q,Wang L,Si J,Zhuo W,Wang L W .2020 .Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS/KRT7. , 11(3) : 511-525.
Chen X,Hao B,Li D,Reiter RJ,Bai Y,Abay B,Chen G,Lin S,Zheng T,Ren Y,Xu X,Li M,Fan L M .2021 .Melatonin inhibits lung cancer development by reversing the Warburg effect via stimulating the SIRT3/PDH axis. J Pineal Res., 71(2) : e12755.
Czapiewski P,Bobowicz M,Peksa R,Skrzypski M,Gorczynski A,Szczepanska-Michalska K,Korwat A,Jankowski M,Zegarski W,Szulgo-Paczkowska A,Polec T,Piatek M,Skokowski J,Haybaeck J,Zaczek A,Biernat W .2016 .Keratin 7 expression in lymph node metastases but not in the primary tumour correlates with distant metastases and poor prognosis in colon carcinoma. Pol. J. Pathol., 67(3) : 228-234.
El-Shami K,Oeffinger KC,Erb NL,Willis A,Bretsch JK,Pratt-Chapman ML,Cannady RS,Wong SL,Rose J,Barbour AL,Stein KD,Sharpe KB,Brooks DD,Cowens-Alvarado RL,Clin RL .2015 .American Cancer Society Colorectal Cancer Survivorship Care Guidelines. , 65(6) : 428-455.
Fan Y,Wang J,Xu Y,Wang Y,Song T,Liang X,Jin F,Su D F .2021 .Anti-warburg effect by targeting HRD1- PFKP pathway may inhibit breast cancer progression. Cell Commun. Signal, 19(1) : 18.
Fei F,Li C,Cao Y,Liu K,Du J,Gu Y,Wang X,Li Y,Zhang S Y .2019 .CK7 expression associates with the location, differentiation, lymph node metastasis, and the Dukes' stage of primary colorectal cancers. J. Cancer, 10(11) : 2510-2519.
Hanahan D,Weinberg RA .2011 .Hallmarks of cancer: The next generation. Cell, 144(5) : 646-674.
Harbaum L,Pollheimer MJ,Kornprat P,Lindtner RA,Schlemmer A,Rehak P,Langner C .2011 .Keratin 7 expression in colorectal cancer - freak of nature or significant finding?. Histopathology, 59(2) : 225-34.
He Y,Yue H,Cheng Y,Xu Z,Lv Z,Wang C,Wang Z,Yin J,Hao C,Chen C H .2021 .ALKBH5- mediated m(6)A demethylation of KCNK15-AS1 inhibits pancreatic cancer progression via regulating KCNK15 and PTEN/AKT signaling. Cell Death Dis., 12(12) : 1121.
Koren A,Sodja E,Rijavec M,Jez M,Kovac V,Korosec P,Cufer T .2015 .Prognostic value of cytokeratin-7 mRNA expression in peripheral whole blood of advanced lung adenocarcinoma patients. Cell Oncol. (Dordr.), 38(5) : 387-95.
Li Y,Su Z,Wei B,Liang Z B .2021 .KRT7 overexpression is associated with poor prognosis and immune cell infiltration in patients with pancreatic adenocarcinoma. Int. J. Gen Med, 14 : 2677-2694.
Li Y,Wang Y,Liu Z,Guo X,Miao Z,Ma S Z .2020 .Atractylenolide I induces apoptosis and suppresses glycolysis by blocking the JAK2/STAT3 signaling pathway in colorectal cancer cells. Front Pharmacol, 11 : 273.
Liberti MV,Locasale JW .2016 .The Warburg effect: How does it benefit cancer cells? Trends Biochem. , 41(3) : 211-218.
Liu H,Zhu Y,Zhang T,Zhao Z,Zhao Y,Cheng P,Li H,Gao H,Su X H .2013 .Anti-tumor effects of atractylenolide I isolated from Atractylodes macrocephala in human lung carcinoma cell lines. Molecules, 18(11) : 13357-13368.
Loupakis F,Biason P,Prete AA,Cremolini C,Pietrantonio F,Pella N,Dell'Aquila E,Sperti E,Zichi C,Intini R,Dadduzio V,Schirripa M,Bergamo F,Antoniotti C,Morano F,Cortiula F,De Maglio G,Rimassa L,Smiroldo V,Calvetti L,Aprile G,Salvatore L,Santini D,Munari G,Salmaso R,Guzzardo V,Mescoli C,Lonardi S,Rugge M,Zagonel V,Di Maio M and Fassan M V .2019 .CK7 and consensus molecular subtypes as major prognosticators in (V600E)BRAF mutated metastatic colorectal cancer. Br. J. Cancer, 121(7) : 593-599.
Ma L,Mao R,Shen K,Zheng Y,Li Y,Liu J,Ni L J .2014 .Atractylenolide I-mediated Notch pathway inhibition attenuates gastric cancer stem cell traits. Biochem. Biophys. Res. Commun., 450(1) : 353-9.
Majumdar D,Tiernan JP,Lobo AJ,Evans CA,Corfe BM .2012 .Keratins in colorectal epithelial function and disease. Int. J. Exp. Pathol., 93(5) : 305-18.
Nie J,Zhao C,Deng LI,Chen J,Yu B,Wu X,Pang P,Chen X .2016 .Efficacy of traditional Chinese medicine in treating cancer. Biomed. Rep, 4(1) : 3-14.
Pachman DR,Qin R,Seisler DK,Smith EM,Beutler AS,Ta LE,Lafky JM,Wagner-Johnston ND,Ruddy KJ,Dakhil S,Staff NP,Grothey A,Loprinzi CL .2015 .Clinical course of oxaliplatin-induced neuropathy: Results from the randomized phase III trial N08CB (Alliance). J. Clin. Oncol., 33(30) : 3416-22.
Paleari L .2022 .Cancer prevention with molecular targeted therapies. Int. J. Mol. Sci, 23(15) : .
Pentimalli F,Grelli S,Di Daniele N,Melino G,Amelio I .2019 .Cell death pathologies: Targeting death pathways and the immune system for cancer therapy. Genes Immun., 20(7) : 539-554.
Polari L,Alam CM,Nystrom JH,Heikkila T,Tayyab M,Baghestani S,Toivola DM .2020 .Keratin intermediate filaments in the colon: Guardians of epithelial homeostasis. Int. J. Biochem. Cell Biol, 129 : 105878.
Qiao P and Tian Z .2022 .Atractylenolide I inhibits EMT and enhances the antitumor effect of cabozantinib in prostate cancer via targeting Hsp27. Front Oncol, 12 : 1084884.
Reinfeld BI,Rathmell WK,Kim TK,Rathmell JC .2022 .The therapeutic implications of immunosuppressive tumor aerobic glycolysis. Cell Mol. Immunol, 19(1) : 46-58.
Spencer NY,Stanton RC .2019 .The Warburg effect, lactate, and nearly a century of trying to cure cancer. Semin Nephrol, 39(4) : 380-393.
Sung H,Ferlay J,Siegel RL,Laversanne M,Soerjomataram I,Jemal A,Bray F A,Clin A .2020 .GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. Global Cancer Statistics, 71(3) : 209-249.
Suzumiya J,Ohshima K,Tamura K,Karube K,Uike N,Tobinai K,Gascoyne RD,Vose JM,Armitage JO,Weisenburger DD .2009 .The international prognostic index predicts outcome in aggressive adult T-cell leukemia/lymphoma: Analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project. , 20(4) : 715-21.
Wang H,Guan L,Li J,Lai M,Wen X .2018 .The Effects of berberine on the gut microbiota in Apc (min/+) mice fed with a high fat diet. Molecules, 23(9) : .
Wang Y,Patti GJ Y .2023 .The Warburg effect: A signature of mitochondrial overload. Trends Cell Biol, 33(12) : 1014-1020.
Wu J,Niu J,Li M,Miao Y .2021 .Keratin 1 maintains the intestinal barrier in ulcerative colitis. Genes Genomics, 43(12) : 1389-1402.
Wu T,Li C,Zhou J,Han L,Qiang S,Hu Z,Liu J,Li X,Zhao W,Chen X .2022 .Primaquine activates Keratin 7 to treat diabetes and its complications. J. Diabetes Metab. Disord., 21(2) : 1731-1741.
Wu Y,Lv M,Qian T,Shen Y .2021 .Correlation analysis of Ki67 and CK7 expression with clinical characteristics and prognosis of postoperative cervical adenocarcinoma patients. Ann. Palliat. Med, 10(9) : 9544-9552.
Xu H,Li L,Qu L,Tu J,Sun X,Liu X,Xu K X .2023 .Atractylenolide-1 affects glycolysis/gluconeogenesis by downregulating the expression of TPI1 and GPI to inhibit the proliferation and invasion of human triplenegative breast cancer cells. Phytother. Res., 37(3) : 820-833.
Xu R,Liu X Tian,Chen D X Tian .2023 .Atractylodes-I overcomes the oxidative stress-induced colonic mucosal epithelial cells dysfunction to prevent irritable bowel syndrome via modulating the miR-34a-5pLDHA signaling pathway. Curr. Mol. Med, 23(8) : 825-833.
Yahyazadeh R,Bashash D,Ghaffari P,Kord S,Safaroghli-Azar A,Ghaffari SH .2021 .Evaluation of hTERT, KRT7, and survivin in urine for noninvasive detection of bladder cancer using real-time PCR. BMC Urology, 21(1) : 64.
Zhang Z,Tu K,Liu F,Liang M,Yu K,Wang Y,Luo Y,Yang B,Qin Y,He D,Jiang G,Huang O,Zou Y .2020 .FoxM1 promotes the migration of ovarian cancer cell through KRT5 and KRT7. , 757 : 144947.
Thompson Zhu J,CB Zhu J .2019 .Metabolic regulation of cell growth and proliferation. Nat. Rev. Mol. Cell Biol, 20(7) : 436-450.
Zhu L,Zhu X,Wu Y .2022 .Effects of glucose metabolism, lipid metabolism, and glutamine metabolism on tumor microenvironment and clinical implications. Biomolecules, 12(4) : 580.
0

Citations

0

Downloads

76

Views